MENU
+Compare
EBS
Stock ticker: NYSE
AS OF
May 9, 04:59 PM (EDT)
Price
$5.65
Change
-$0.71 (-11.16%)
Capitalization
120.07M

EBS Emergent Biosolutions Forecast, Technical & Fundamental Analysis

Emergent BioSolutions Inc offers public health products to the government and healthcare providers... Show more

Industry: #Biotechnology
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EBS with price predictions
May 08, 2025

Aroon Indicator for EBS shows an upward move is likely

EBS's Aroon Indicator triggered a bullish signal on May 06, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 171 similar instances where the Aroon Indicator showed a similar pattern. In of the 171 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where EBS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 08, 2025. You may want to consider a long position or call options on EBS as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

EBS moved above its 50-day moving average on May 08, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where EBS advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EBS broke above its upper Bollinger Band on May 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.185) is normal, around the industry mean (61.504). P/E Ratio (17.730) is within average values for comparable stocks, (90.857). EBS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.115) is also within normal values, averaging (19.413).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EBS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EBS is expected to report earnings to fall 74.65% to 18 cents per share on August 12

Emergent Biosolutions EBS Stock Earnings Reports
Q2'25
Est.
$0.18
Q1'25
Beat
by $0.22
Q4'24
Beat
by $0.46
Q3'24
Beat
by $1.27
Q2'24
Missed
by $1.37
The last earnings report on May 07 showed earnings per share of 70 cents, beating the estimate of 49 cents. With 775.75K shares outstanding, the current market capitalization sits at 120.07M.
A.I. Advisor
published General Information

General Information

a manufacturer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
300 Professional Drive
Phone
+1 240 631-3200
Employees
1600
Web
https://www.emergentbiosolutions.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NINOY10.060.46
+4.79%
Nikon Corp.
FCVTX17.37N/A
N/A
Fidelity Advisor Small Cap Value M
TPISX11.77N/A
N/A
Nuveen Quant Intl Small Cap Eq Premier
VVIMX12.02N/A
N/A
Voya VACS Index MC
HYSR0.02N/A
-0.18%
SunHydrogen Inc.

EBS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with AMRX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
+34.18%
AMRX - EBS
33%
Loosely correlated
+3.32%
HROW - EBS
31%
Poorly correlated
-4.07%
ZOMDF - EBS
29%
Poorly correlated
-2.44%
SNDL - EBS
27%
Poorly correlated
+0.77%
SIGA - EBS
27%
Poorly correlated
+3.62%
More